Scientists supercharge Patient's own cells to hunt childhood cancers

NCT ID NCT01953900

Summary

This early-stage study is testing a new combination treatment for children and young adults with advanced osteosarcoma or neuroblastoma that has come back or hasn't responded to standard therapies. Doctors take a patient's own immune cells, genetically modify them to better recognize and attack cancer, and infuse them back along with a chickenpox vaccine. The main goals are to find a safe dose, check for side effects, and see if this approach can help control these difficult cancers.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOSARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Houston Methodist Hospital

    Houston, Texas, 77030, United States

  • Texas Children's Hospital

    Houston, Texas, 77030, United States

Conditions

Explore the condition pages connected to this study.